| 1 |
Nobleza COS.Intracerebral hemorrhage [J].Continuum (Minneap Minn), 2021, 27(5): 1246-1277.
|
| 2 |
Carpenter AM, Singh IP, Gandhi CD, et al.Genetic risk factors for spontaneous intracerebral haemorrhage [J].Nat Rev Neurol, 2016,12(1): 40-49.
|
| 3 |
Greenberg SM, Ziai WC, Cordonnier C, et al.2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage:a guideline from the American Heart Association/American Stroke Association [J].Stroke, 2022, 53(7): e282-e361.
|
| 4 |
Khan NI, Siddiqui FM, Goldstein JN, et al.Association between previous use of antiplatelet therapy and intracerebral hemorrhage outcomes [J].Stroke, 2017, 48(7): 1810-1817.
|
| 5 |
Li Y, Liu X, Chen S, et al.Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage [J].CNS Neurosci Ther, 2023, 29(6): 1484-1496.
|
| 6 |
Marcolini E, Stretz C, DeWitt KM.Intracranial hemorrhage and intracranial hypertension [J].Emerg Med Clin North Am, 2019, 37(3):529-544.
|
| 7 |
Udge C, Ruttledge S, Costello M, et al.Lipid lowering therapy, lowdensity lipoprotein level and risk of intracerebral hemorrhage - a metaanalysis [J].J Stroke Cerebrovasc Dis, 2019, 28(6): 1703-1709.
|
| 8 |
Byrne RA, Rossello X, Coughlan JJ, et al.2023 ESC guidelines for the management of acute coronary syndromes [J].Eur Heart J, 2023,44(38): 3720-3826.
|
| 9 |
Natsuaki M, Watanabe H, Morimoto T, et al.An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial [J].Circulation, 2024, 149(8): 585-600.
|
| 10 |
Kim CJ, Park MW, Kim MC, et al.Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI):an investigator-initiated, open-label, multicentre, non-inferiority,randomized trial [J].Lancet, 2021, 398(10308): 1305-1316.
|
| 11 |
Koo BK, Kang J, Park KW, et al.Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective,randomised, open-label, multicentre trial [J].Lancet, 2021,397(10293): 2487-2496.
|
| 12 |
Gragnano F, Cao D, Pirondini L, et al.P2Y12 inhibitor or aspirin monotherapy for secondary prevention of coronary events [J].J Am Coll Cardiol, 2023, 82(2): 89-105.
|
| 13 |
Scott RM, Smith ER.Moyamoya disease and moyamoya syndrome [J].N Engl J Med, 2009, 360(12): 1226-1237.
|
| 14 |
Primary P, Bainey KR, Marquis-Gravel G, et al.Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 focused update of the guidelines for the use of antiplatelet therapy [J].Can J Cardiol, 2024, 40(2): 160-181.
|
| 15 |
Butcher KS, Jeerakathil T, Hill M, et al.The intracerebral hemorrhage acutely decreasing arterial pressure trial [J].Stroke, 2013, 44(3): 620-626.
|
| 16 |
Anderson CS, Huang Y, Wang JG, et al.Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT):a randomised pilot trial [J].Lancet Neurol, 2008, 7(5): 391-399.
|
| 17 |
Zhao JL, Du ZY, Sun YR, et al.Intensive blood pressure control reduces the risk of progressive hemorrhage in patients with acute hypertensive intracerebral hemorrhage: a retrospective observational study [J].Clin Neurol Neurosurg, 2019, 180: 1-6.
|
| 18 |
Moullaali TJ, Wang X, Martin RH, Et al.Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data [J].Lancet Neurol, 2019,18(9): 857-864.
|
| 19 |
张谦, 冀瑞俊, 赵萌, 等.中国脑血管病临床管理指南(第2 版)(节选)——第5 章脑出血临床管理 [J].中国卒中杂志, 2023, 18(9):1014-1023.
|
| 20 |
Sandset EC, Anderson CS, Bath PM, et al.European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage [J].Eur Stroke J,2021, 6(2): XLVIII-LXXXIX.
|
| 21 |
Greenberg SM, Ziai WC, Cordonnier C, et al.2022 guideline for the management of patients with spontaneous intracerebral hemorrhage:a guideline from the American Heart Association/American Stroke Association [J].Stroke, 2022, 53(7): e282-e361.
|
| 22 |
Post R, Germans MR, Tjerkstra MA, et al.Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial [J].Lancet, 2021, 397(10269): 112-118.
|
| 23 |
Selim M, Foster LD, Moy CS, et al.Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised,placebo-controlled, double-blind phase 2 trial [J].Lancet Neurol,2019, 18(5): 428-438.
|
| 24 |
Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al.Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH):a randomised, open-label, phase 3 trial [J].Lancet, 2016, 387(10038):2605-2613.
|
| 25 |
Ramakumar V.Platelet blockage: prasugrel versus ticagrelor:intracoronary stenting and antithrombotic regimen: rapid early action for coronary treatment [J].J Pract Cardiovasc S, 2019, 5(3): 154-156.
|
| 26 |
Murthy SB, Biffi A, Falcone GJ, et al.Antiplatelet therapy after spontaneous intracerebral hemorrhage and functional outcomes [J].Stroke, 2019, 50(11): 3057-3063.
|
| 27 |
RESTART Collaboration.Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, openlabel trial [J].Lancet, 2019, 393(10191): 2613-2623.
|
| 28 |
Al-Shahi SR, Greenberg SM.Antiplatelet agent use after stroke due to intracerebral hemorrhage [J].Stroke, 2023, 54(12): 3173-3181.
|
| 29 |
Cao X, Wei M, Tang M.et al.Acute myocardial infarction and concomitant acute intracranial hemorrhage: clinical characteristics and outcomes [J].J Investig Med, 2022, 70(8): 1713-1719.
|
| 30 |
Zhang P, Pang S, Du L, et al.Clinical characteristics and outcomes of patients with intracerebral hemorrhage after acute myocardial infarction [J].Int J Cardiol, 2023, 390: 131218.
|
| 31 |
Hiatt WR, Fowkes FG, Heizer G, et al.Ticagrelor versus clopidogrel in symptomatic peripheral artery disease [J].N Engl J Med, 2017,376(1): 32-40.
|
| 32 |
Wallentin L, Becker RC, Budaj A, et al.Ticagrelor versus clopidogrel in patients with acute coronary syndromes [J].N Engl J Med, 2009,361(11): 1045-1057.
|
| 33 |
Ha ACT, Bhatt DL, Rtuka JT, et al.Intracranial hemorrhage during dual antiplatelet therapy: JACC review topic of the week [J].J Am Coll Cardiol, 2021, 78(13): 1372-1384.
|
| 34 |
中国医药教育协会急诊医学分会, 中华医学会急诊医学分会心脑血管学组, 急性血栓性疾病急诊专家共识组.中国急性血栓性疾病抗栓治疗共识 [J].中国急救医学, 2019, 39(6): 501-531.
|